Skip to content
CharitiesAidWelfare, Medical Health Aged Care

Increase efforts to advance health outcomes amid regionalisation ambition

National Rural Health Alliance 2 mins read

The National Rural Health Alliance (the Alliance) is pleased to see the recent unveiling of the Regionalisation Ambition 2032 Year 1 Progress Report by Regional Australia Institute at the Regions Rising National Summit – Shifting our Gaze.

The Alliance supports the Ambition and is a founding member of the National Alliance for Regionalisation initiative to ‘Rebalance the Nation.’

“We are pleased that the progress report highlights that regional Australia is a better place to live, work and invest than it was 12 months ago”.

“As such, we encourage federal and state governments to double their efforts to provide health dividends to the regions, with increased funding and services. These efforts need to be locally led and flexible to build what is needed,” said the Alliance Chief Executive Susi Tegen.

“The Alliance continues to work and advocate for better healthcare access in rural and regional areas. We know that by supporting Australians to be healthier, rural and regional populations thrive, and they can continue to be the economic powerhouse they are,” Ms Tegen added.

“Non-urban industries represent a substantial proportion of Australia’s economic output, while representing just 30 percent of the population. Australia’s prosperity and ability to weather financial crises and economic downturns have been because of the contribution of rural, regional and remote industries and populations.

“Therefore, while we join in the call for regionalisation, we urge that governments take heed to this enthusiasm and capacity to ensure better health outcomes to our regions,” Ms Tegen concluded.


About us:

The National Rural Health Alliance (the Alliance) comprises 47 national organisations committed to improving the health and wellbeing of the 7 million people in rural and remote Australia. Our diverse membership includes representation from the Aboriginal and Torres Strait Islander health sector, health professional organisations, health service providers, health educators and students.


Contact details:

Kathya de Silva

Media and Communications Officer

[email protected]

0470 487 608

Media

More from this category

  • Legal, Medical Health Aged Care
  • 10/03/2026
  • 17:30
Maddens Lawyers

Thousands register to participate in the Dr Lanzer Class Action

Patients who underwent cosmetic surgery at the Lanzer Clinics have until 4.00pm Friday 10 April to register or opt out of a class action set for trial in the Supreme Court of Victoria in September. The class action alleges that Dr Daniel Lanzer and his colleagues Dr Daniel Aronov, Dr Ryan Wells, Dr Alieza Fallahi, Dr George Wong, and Dr Daniel Darbyshire engaged in misleading and negligent practices while performing cosmetic surgeries, with many former patients left with injuries and ongoing pain. Psychologist Candice Wainstein, who is the wife of Dr Aronov, is also a defendant. Maddens Lawyers principal Kathryn…

  • Contains:
  • CharitiesAidWelfare, International News
  • 10/03/2026
  • 17:00
Tuesday, 10 March 2026

MEDIA ALERT – Children bearing the brunt as Middle East escalation displaces hundreds of thousands in Lebanon

More than 500,000 people have been displaced in Lebanon as the Middle East crisis escalates into its second week. Across the region, thousands of children and families face imminent violence and an increasing risk of death, displacement, trauma and injury. Children are bearing the brunt of this conflict, with more than half of the 200 million children in the region living in a conflict-affected setting. Before the current escalation, 1.4 million children in Lebanon were already at risk, including nearly 420,000 school-aged children out of school. More than 80% of collective shelters are now hosted in school buildings, further disrupting…

  • Medical Health Aged Care
  • 10/03/2026
  • 16:28
Phebra

Phebra launches Rapiblyk® in Australian healthcare settings

Australian Pharmaceutical company Phebra (‘Company’) has announced the launch of Rapiblyk® (landiolol hydrochloride), an ultra‑short‑acting, cardio-selective receptor antagonist, indicated for rapid control of ventricular rate in patients with severe, acute cardiac arrhythmias (irregular rapid heart rate) in critical care settings. Clinical studies have demonstrated that Rapiblyk® enables safe, effective heart rate control with limited impact on blood pressure and inotropy (heart contractility). Rapiblyk® has a very short half life delivering a fast onset and offset of action. This provides clinicians with a higher level of precision in life-threatening situations. Phebra CEO Andre Vlok highlighted how Rapiblyk® strengthens the company's critical…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.